An mRNA Vaccine Encoding Rabies Virus Glycoprotein Induces Protection against Lethal Infection in Mice and Correlates of Protection in Adult and Newborn Pigs

• Margit Schnee ,

  Contributed equally to this work with: Margit Schnee, Annette B. Vogel

  Affiliation CureVac AG, Tübingen, Germany

  ⨯
• Annette B. Vogel ,

  Contributed equally to this work with: Margit Schnee, Annette B. Vogel

  Current Address: BioNTech RNA Pharmaceuticals GmbH, Mainz, Germany

  Affiliation Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany

  ⨯
• Daniel Voss,

  Current Address: Roche Pharma AG, Grenzach-Wyhlen, Germany

  Affiliation CureVac AG, Tübingen, Germany

  ⨯
• Benjamin Petsch ,

  * E-mail: benjamin.petsch@curevac.com (BP); lothar.stitz@gmx.de (LS)

  Affiliation CureVac AG, Tübingen, Germany

  ⨯
• Patrick Baumhof,

  Affiliation CureVac AG, Tübingen, Germany

  ⨯
• Thomas Kramps,

  Current Address: Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany

  Affiliation CureVac AG, Tübingen, Germany

  ⨯
• Lothar Stitz

  * E-mail: benjamin.petsch@curevac.com (BP); lothar.stitz@gmx.de (LS)

  Affiliation Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany

  ⨯